| Item Type | Name |
|
Concept
|
Antigen-Presenting Cells
|
|
Concept
|
Antigens, Ly
|
|
Concept
|
Antigens
|
|
Concept
|
Antigens, Bacterial
|
|
Concept
|
Histocompatibility Antigens Class II
|
|
Concept
|
Sensitivity and Specificity
|
|
Concept
|
CD28 Antigens
|
|
Concept
|
Histocompatibility Antigens Class I
|
|
Concept
|
Antigens, CD
|
|
Concept
|
Receptors, Antigen, T-Cell, alpha-beta
|
|
Concept
|
B7-H1 Antigen
|
|
Concept
|
CTLA-4 Antigen
|
|
Concept
|
T-Lymphocytes, Regulatory
|
|
Concept
|
Receptors, Antigen, T-Cell
|
|
Concept
|
Thymus Gland
|
|
Academic Article
|
Activation-induced expression of MICA on T lymphocytes involves engagement of CD3 and CD28.
|
|
Academic Article
|
Up-regulated expression of MICA on activated T lymphocytes involves Lck and Fyn kinases and signaling through MEK1/ERK, p38 MAP kinase, and calcineurin.
|
|
Academic Article
|
Up-regulated expression of MICA and proinflammatory cytokines in skin biopsies from patients with seborrhoeic dermatitis.
|
|
Academic Article
|
Role of natural killer cell subsets in cardiac allograft rejection.
|
|
Academic Article
|
NF-kappa B regulates expression of the MHC class I-related chain A gene in activated T lymphocytes.
|
|
Academic Article
|
Low-dose radiation enhances survivin-mediated virotherapy against malignant glioma stem cells.
|
|
Academic Article
|
Decreased percentage of CD4+FoxP3+ cells in bronchoalveolar lavage from lung transplant recipients correlates with development of bronchiolitis obliterans syndrome.
|
|
Academic Article
|
T-cell receptor-induced NF-kappaB activation is negatively regulated by E3 ubiquitin ligase Cbl-b.
|
|
Academic Article
|
A critical role for protein kinase C-theta-mediated T cell survival in cardiac allograft rejection.
|
|
Academic Article
|
Intracellular retention of the NKG2D ligand MHC class I chain-related gene A in human melanomas confers immune privilege and prevents NK cell-mediated cytotoxicity.
|
|
Academic Article
|
High TCR stimuli prevent induced regulatory T cell differentiation in a NF-?B-dependent manner.
|
|
Academic Article
|
CARMA1 controls an early checkpoint in the thymic development of FoxP3+ regulatory T cells.
|
|
Academic Article
|
T cell receptor/CARMA1/NF-?B signaling controls T-helper (Th) 17 differentiation.
|
|
Academic Article
|
Codominant expression of the polymorphic MICA alloantigens encoded by genes in the HLA region.
|
|
Academic Article
|
Intracellular expression of MICA in activated CD4 T lymphocytes and protection from NK cell-mediated MICA-dependent cytotoxicity.
|
|
Academic Article
|
Cloning, expression and interaction of human T-cell receptors with the bacterial superantigen SSA.
|
|
Academic Article
|
Basal NF-?B controls IL-7 responsiveness of quiescent naïve T cells.
|
|
Academic Article
|
ß-Catenin promotes colitis and colon cancer through imprinting of proinflammatory properties in T cells.
|
|
Academic Article
|
The composition of the microbiota modulates allograft rejection.
|
|
Academic Article
|
Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast Cancer: A Phase 1 Study.
|
|
Academic Article
|
Safety and clinical activity of atezolizumab in head and neck cancer: results from a phase I trial.
|
|
Academic Article
|
A PK/PD Analysis of Circulating Biomarkers and Their Relationship to Tumor Response in Atezolizumab-Treated non-small Cell Lung Cancer Patients.
|
|
Academic Article
|
Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of Atezolizumab.
|
|
Academic Article
|
Tumor immune microenvironment and genomic evolution in a patient with metastatic triple negative breast cancer and a complete response to atezolizumab.
|
|
Academic Article
|
Safety and Clinical Activity of Atezolizumab Plus Bevacizumab in Patients with Ovarian Cancer: A Phase Ib Study.
|
|
Academic Article
|
Prevalence Study of PD-L1 SP142 Assay in Metastatic Triple-negative Breast Cancer.
|
|
Academic Article
|
Enrichment of circulating tumor-derived extracellular vesicles from human plasma.
|
|
Academic Article
|
Atezolizumab and nab-Paclitaxel in Advanced Triple-Negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study.
|
|
Academic Article
|
Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39).
|
|
Academic Article
|
PD-L1 Immunohistochemistry Assay Comparison in Atezolizumab Plus nab-Paclitaxel-Treated Advanced Triple-Negative Breast Cancer.
|
|
Academic Article
|
Molecular determinants of response to PD-L1 blockade across tumor types.
|
|
Academic Article
|
Influence of Genomic Landscape on Cancer Immunotherapy for Newly Diagnosed Ovarian Cancer: Biomarker Analyses from the IMagyn050 Randomized Clinical Trial.
|
|
Academic Article
|
CD8+ T cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy.
|
|
Concept
|
AC133 Antigen
|
|
Academic Article
|
Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer.
|